Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acquired Pure Red Cell Aplasia”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07031115
What this trial is testing

Linperlisib in the Treatment of aPRCA

Who this might be right for
Acquired Pure Red Cell Aplasia
Peking Union Medical College Hospital 15
Testing effectiveness (Phase 2)Study completedNCT03513328
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

Who this might be right for
Bone Marrow Failure SyndromeThalassemiaSickle Cell Disease+13 more
University of Florida 6
Testing effectiveness (Phase 2)Study completedNCT04423367
What this trial is testing

Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

Who this might be right for
Acquired Pure Red Cell Aplasia
Institute of Hematology & Blood Diseases Hospital, China 18
Testing effectiveness (Phase 2)Looking for participantsNCT06412497
What this trial is testing

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

Who this might be right for
Severe Aplastic AnemiaAcquired Amegakaryocytic ThrombocytopeniaAcquired Pure Red Cell Aplasia+1 more
Masonic Cancer Center, University of Minnesota 60
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Not applicableLooking for participantsNCT04781790
What this trial is testing

French National Registry of Bone Marrow Failures

Who this might be right for
Bone Marrow Failure Syndrome
Assistance Publique - Hôpitaux de Paris 5,000
Not applicableUnknownNCT00315419
What this trial is testing

Identifying Characteristics of Bone Marrow Failure Syndromes

Who this might be right for
Bone Marrow Failure SyndromesAnemia, AplasticMyelodysplastic Syndromes+4 more
Office of Rare Diseases (ORD) 450
Post-approval studies (Phase 4)Study completedNCT04470804
What this trial is testing

Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA

Who this might be right for
Pure Red Cell Aplasia, Acquired
Bing Han 56
Post-approval studies (Phase 4)Study completedNCT00673608
What this trial is testing

Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload

Who this might be right for
HemoglobinopathiesMyelodysplastic SyndromesOther Inherited or Acquired Anaemia+4 more
Novartis 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT01966367
What this trial is testing

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

Who this might be right for
Bone Marrow Failure SyndromeSevere Aplastic AnemiaSevere Congenital Neutropenia+13 more
Diane George 37